Use of hepatocyte-specific PPARδ null mice identified that hepatic PPARβ/δ augments FA muscle utilization and improves dyslipidemia through a metabolic network between hepatic PPARβ/δ and muscle PPARα. Here, PPARD is linked to metabolic syndrome.